ROSE12
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ROSE12, covering 2025-03-06 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors [Phase 1]